Previously banned drug becomes anti-cancer superhero

Recent studies support thalidomide’s use against blood cancers like multiple myeloma (MM) and suggest that the drug can help target cancer-promoting agents that were previously drug resistant. Additionally, it produced better survival rates in MM patients than other drugs in a recent trial.

In 10 seconds? Thalidomide, notorious for birth defects in the 1960s is now routinely used to treat multiple myeloma, but researchers have discovered more of its hidden powers that can help target other cancers.